Emory researchers: 'Very encouraging' results in Covid-19 vaccine phase 1 trial
July 15, 2020 at 07:06 AM EDT
The vaccine produced "a good immune response," and trial participants suffered no serious adverse events, investigators reported. The second phase of the trial is ongoing and a third phase will launch this month.